Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT05478512
Title Front-line VenObi Combination Followed by Ven or VenZan Combination in Patients With Residual Disease: a MRD Tailored Treatment for Young Patients With High-risk CLL (VIS)
Acronym VIS
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Gruppo Italiano Malattie EMatologiche dell'Adulto
Indications
Therapies
Age Groups: adult | senior
Covered Countries ITA

Facility Status City State Zip Country Details
Ematologia AOU Careggi RECRUITING Firenze Italy Details
Ematologia IRST D.Amadori RECRUITING Meldola Italy Details
Ematologia AO di Perugia RECRUITING Perugia Italy Details
Ematologia Ospedale S.M. delle Croci RECRUITING Ravenna Italy Details
Ematologia Ospedale Infermi RECRUITING Rimini Italy Details
Ematologia Policlinico Gemelli RECRUITING Roma Italy Details
Ematologia Policlinico Umberto I RECRUITING Roma Italy Details
Ematologia AOUS - Policlinico S. M. alle Scotte RECRUITING Siena Italy Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field